CLINICAL_TRIALS
trial_result
· 2026-03-11
Clinical Trial Update: A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)
Summary
This completed UK clinical trial evaluated recombinant von Willebrand factor used on demand and for prevention and treatment of bleeding during and after surger…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Von Willebrand Disease (VWD) | Status: COMPLETED